What's in Atea Pharmaceuticals, Inc.'s pipeline?

Atea Pharmaceuticals, Inc. has 7 drugs in our index: 0 marketed, 0 filed, 2 in Phase 3, 0 in Phase 2, 5 in Phase 1.

Which companies overlap with Atea Pharmaceuticals, Inc.'s portfolio?

Top competitors by shared drug class: Bausch & Lomb Incorporated, Medivir, Tarapeutics Science Inc..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/atea-pharmaceuticals-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

Atea Pharmaceuticals, Inc. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Atea Pharmaceuticals, Inc. pipeline: 0 marketed, 0 filed, 2 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 2 Phase 3 0 Phase 2 5 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Bemnifosbuvir-Ruzasvir	Bemnifosbuvir-Ruzasvir	phase 3	Direct-acting antiviral (DAA) combination; nucleoside polymerase inhibitor + NS5A inhibitor	HCV NS5B RNA-dependent RNA polymerase; HCV NS5A protein	Infectious Disease / Virology
Bemnifosbuvir (BEM)	Bemnifosbuvir (BEM)	phase 3	Nucleoside analog; viral polymerase inhibitor	Viral RNA-dependent RNA polymerase (RdRp)	Virology; Infectious Disease

Therapeutic area mix

Infectious Disease · 2
Infectious Disease / Virology · 1
Virology; Infectious Disease · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Bausch & Lomb Incorporated · 1 shared drug class
Medivir · 1 shared drug class
Tarapeutics Science Inc. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Atea Pharmaceuticals, Inc.:

Cite this brief

Drug Landscape (2026). Atea Pharmaceuticals, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/atea-pharmaceuticals-inc. Accessed 2026-06-10.